Tocqueville Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21,415
| Closed | -$385K | – | 684 |
|
|
2020
Q2 | $385K | Hold |
21,415
| – | – | 0.01% | 531 |
|
|
2020
Q1 | $153K | Sell |
21,415
-376,488
| -95% | -$4.7M | ﹤0.01% | 606 |
|
|
2019
Q4 | $9.5M | Sell |
397,903
-185
| -0% | -$5.1K | 0.14% | 165 |
|
|
2019
Q3 | $10.7M | Sell |
398,088
-70,026
| -15% | -$1.97M | 0.14% | 170 |
|
|
2019
Q2 | $12.7M | Sell |
468,114
-8,631
| -2% | -$271K | 0.16% | 160 |
|
|
2019
Q1 | $16.5M | Sell |
476,745
-128,840
| -21% | -$3.72M | 0.22% | 128 |
|
|
2018
Q4 | $11.8M | Buy |
605,585
+168,905
| +39% | +$3.47M | 0.18% | 148 |
|
|
2018
Q3 | $11.6M | Buy |
436,680
+104,590
| +31% | +$3.41M | 0.15% | 178 |
|
|
2018
Q2 | $12.5M | Buy |
+332,090
| New | +$12.7M | 0.16% | 162 |
|
|
2016
Q2 | – | Sell |
-10,650
| Closed | -$217K | – | 892 |
|
|
2016
Q1 | $217K | Sell |
10,650
-34,200
| -76% | -$1.09M | ﹤0.01% | 793 |
|
|
2015
Q4 | $2.31M | Buy |
44,850
+4,900
| +12% | +$238K | 0.03% | 397 |
|
|
2015
Q3 | $1.7M | Buy |
39,950
+24,950
| +166% | +$1.2M | 0.02% | 469 |
|
|
2015
Q2 | $683K | Buy |
15,000
+3,500
| +30% | +$141K | 0.01% | 643 |
|
|
2015
Q1 | $437K | Buy |
+11,500
| New | +$395K | 0.01% | 746 |
|
Tocqueville Asset Management's PTLA Position: Q3 2020 in Review
Tocqueville Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 21,415 shares — an estimated $385K sold.
Tocqueville Asset Management first reported a position in PTLA in Q1 2015 and held it in 14 quarters. The position peaked at $16.5M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Tocqueville Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Tocqueville Asset Management sold 21,415 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $385K.
- Tocqueville Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 14 quarters.
- Tocqueville Asset Management's Portola Pharmaceuticals, Inc. position peaked at $16.5M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.